Acorda Therapeutics (ACOR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ACOR | AMGN | BMY | GILD | VRTX |
| Company | Acorda Therapeutics | Amgen Inc | Bristol-Myers Squibb Company | Gilead Sciences Inc | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NYSE | NASDAQ | NASDAQ |
| Open | 0.7800 | 334.56 | 48.27 | 76.03 | 493.14 |
| High | 0.8500 | 338.94 | 50.61 | 78.29 | 502.97 |
| Low | 0.6116 | 333.28 | 47.73 | 75.74 | 492.17 |
| Last | 0.6610 | 334.85 | 50.45 | 77.01 | 495.26 |
| Change | -0.2187 | +0.55 | +5.18 | +0.50 | +3.00 |
| % Change | -24.86% | +0.16% | +11.44% | +0.65% | +0.61% |
| Volume | 416,900 | 1,515,400 | 36,636,400 | 7,453,600 | 774,100 |
| 20-Day Average Volume | 396,280 | 1,897,160 | 17,120,881 | 6,406,350 | 1,086,435 |
| Previous Close | 0.8797 | 334.30 | 45.27 | 76.51 | 492.26 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 8.1538 | 324.73 | 42.09 | 70.77 | 485.57 |
| 20-Day Raw Stochastic | 0.37% | 70.54% | 98.58% | 89.58% | 77.01% |
| 20-Day Relative Strength | 20.79% | 65.60% | 75.30% | 69.91% | 65.12% |
| Weighted Alpha | -37.54 | +41.43 | -12.01 | +3.58 | +44.06 |
| Today's Opinion | 100% Sell | 100% Buy | 8% Buy | 24% Buy | 100% Buy |
| Previous Opinion | 100% Sell | 100% Buy | 56% Sell | 24% Buy | 100% Buy |
| Last Month's Opinion | 24% Sell | 100% Buy | 88% Sell | 56% Sell | 100% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -60.65% since 04/04/24 | +1.07% since 07/19/24 | +18.32% since 07/19/24 | +6.13% since 07/19/24 | +0.75% since 07/19/24 |
| Low | 0.6116 on 04/11/24 | 330.34 on 07/24/24 | 41.90 on 07/23/24 | 70.78 on 07/23/24 | 486.25 on 07/24/24 |
| High | 1.6214 on 04/05/24 | 346.85 on 07/25/24 | 50.61 on 07/26/24 | 78.29 on 07/26/24 | 503.99 on 07/25/24 |
| 1-Month | |||||
| %Chg | -94.49% since 03/11/24 | +7.04% since 06/26/24 | +18.71% since 06/26/24 | +11.11% since 06/26/24 | +4.49% since 06/26/24 |
| Low | 0.6116 on 04/11/24 | 306.11 on 07/03/24 | 39.35 on 07/05/24 | 66.01 on 07/05/24 | 466.01 on 07/03/24 |
| High | 14.1100 on 03/15/24 | 346.85 on 07/25/24 | 50.61 on 07/26/24 | 78.29 on 07/26/24 | 503.99 on 07/25/24 |
| 3-Month | |||||
| %Chg | -95.96% since 01/11/24 | +24.03% since 04/26/24 | +12.49% since 04/26/24 | +17.72% since 04/26/24 | +24.60% since 04/26/24 |
| Low | 0.6116 on 04/11/24 | 268.99 on 04/29/24 | 39.35 on 07/05/24 | 62.07 on 05/31/24 | 391.70 on 04/30/24 |
| High | 18.0000 on 01/18/24 | 346.85 on 07/25/24 | 50.61 on 07/26/24 | 78.29 on 07/26/24 | 503.99 on 07/25/24 |
| 6-Month | |||||
| %Chg | -93.85% since 10/11/23 | +7.40% since 01/26/24 | +1.51% since 01/26/24 | -3.16% since 01/26/24 | +15.13% since 01/26/24 |
| Low | 0.6116 on 04/11/24 | 260.68 on 04/19/24 | 39.35 on 07/05/24 | 62.07 on 05/31/24 | 391.01 on 04/18/24 |
| High | 18.0000 on 01/18/24 | 346.85 on 07/25/24 | 55.03 on 03/13/24 | 80.00 on 01/29/24 | 503.99 on 07/25/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 821 | 179,330,224 | 91,766,816 | 95,320,224 | 127,029,184 |
| Shares Outstanding, K | 1,242 | 536,435 | 2,027,100 | 1,245,853 | 258,053 |
| Annual Sales | 117,630,000 | 28,190,000,000 | 45,006,000,000 | 27,116,000,000 | 9,869,200,000 |
| Annual Net Income | -252,850,000 | 6,717,000,000 | 8,025,000,000 | 5,665,000,000 | 3,619,600,000 |
| Last Quarter Sales | 37,990,000 | 7,447,000,000 | 11,865,000,000 | 6,686,000,000 | 2,690,600,000 |
| Last Quarter Net Income | -217,760,000 | -113,000,000 | -11,911,000,000 | -4,170,000,000 | 1,099,600,000 |
| 60-Month Beta | 1.40 | 0.58 | 0.44 | 0.18 | 0.39 |
| Per-Share Information | |||||
| Most Recent Earnings | -175.32 on 04/01/24 | 3.96 on 05/02/24 | -4.40 on 04/25/24 | -1.32 on 04/25/24 | 4.76 on 05/06/24 |
| Latest Earnings Date | 05/09/24 | 08/06/24 | 07/26/24 | 08/08/24 | 08/01/24 |
| Most Recent Dividend | N/A | 2.250 on 05/16/24 | 0.600 on 07/05/24 | 0.770 on 06/14/24 | N/A |
| Next Ex-Dividends Date | N/A | 05/16/24 | 07/05/24 | 06/14/24 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 18.01 | 42.53 | 18.24 | 32.59 |